The current study was designed to examine, on one hand, the potential pro-inflammatory role of TNF-β (lymphotoxin α) to promote tumour inflammatory microenvironment and thus enhance the malignant potential of CRC cells individually or during treatment with the chemotherapeutic drug 5-FU. This evidence concerns the gene LTA and neoplasm.